The introduction of biosimilars of low molecular weight heparins in Europe: a critical review and reappraisal endorsed by the Italian Society for Haemostasis and Thrombosis (SISET) and the Italian Society for Angiology and Vascular Medicine (SIAPAV)

Recently, the European Medicines Agency (EMA) authorized the introduction and marketing of Thorinane® and Inhixa®, biosimilars of the Low Molecular Weight Heparin (LMWH) enoxaparin. The authorization path is considerably different from the guidelines published by the EMA in 2009, as well as from the...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Thromb J
Auteurs principaux: Imberti, Davide, Marietta, Marco, Polo Friz, Hernan, Cimminiello, Claudio
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5424282/
https://ncbi.nlm.nih.gov/pubmed/28490974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-017-0136-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires